View:
- -
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
July 19, 2002
- ------------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
- ------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------------- ----------- --------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
- -------------------------------------------------------
(Address of principal executive offices)
336-229-1127
- ------------
(Registrant's telephone number, including area code)
ITEM 5. OTHER EVENTS
Laboratory Corporation of America -Registered Trademark-Holdings
(LabCorp -Registered Trademark-)(NYSE:LH) expects to release second
quarter financial results at approximately 5:00 p.m. Eastern Time on
July 24, 2002. A conference call has been scheduled for Thursday, July
25, 2002 at 9:00 a.m. Eastern Time to discuss the results. Thomas P. Mac
Mahon, Chairman and Chief Executive Officer, will host the call.
A live broadcast of LabCorp's second quarter conference call on July
25, 2002 will be available online at www.labcorp.com or at
www.streetevents.com beginning at 9:00 a.m. Eastern Time, with an online
rebroadcast continuing through August 25, 2002. The live call at 9:00 a.m.
is also available in a listen-only mode by dialing 212-896-6115. A
telephone replay of the call will be available through August 1, 2002
and can be heard by dialing 800-633-8284 (402-977-9140 for
international callers). The access code for the replay is 207-60-417.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
INFORMATION AND EXHIBITS
(c) Exhibit
20 Press release of the Company dated July 19, 2002.
SIGNATURES
Pursuant to the requirements of the Securities and
Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By:/s/ BRADFORD T. SMITH
--------------------------------
Bradford T. Smith
Executive Vice President
and Secretary
Date: July 19, 2002
Laboratory Corporation of America-Registered Trademark- Holdings
358 South Main Street
Burlington, NC 27215
Telephone: 336-584-5171
FOR IMMEDIATE RELEASE
Contact: 336-436-4855 Shareholder Direct: 800-LAB-0401
Pamela Sherry www.labcorp.com
Investor@labcorp.com
LABORATORY CORPORATION OF AMERICA-
REGISTERED TRADEMARK-
SCHEDULES SECOND QUARTER 2002 RESULTS
CONFERENCE CALL
Burlington, NC, July 19, 2002 -Laboratory Corporation of
America-Registered Trademark- Holdings (LabCorp-Registered
Trademark-) (NYSE: LH) expects to release second
quarter financial results at approximately 5:00 p.m. Eastern Time
on July 24, 2002. A conference call has been scheduled for
Thursday, July 25, 2002 at 9:00 a.m. Eastern Time to discuss the
results. Thomas P. Mac Mahon, Chairman and Chief Executive
Officer, will host the call.
A live broadcast of LabCorp's second quarter conference call on
July 25, 2002 will be available online at www.labcorp.com or at
www.streetevents.com beginning at 9:00 a.m. Eastern Time, with
an online rebroadcast continuing through August 25, 2002. The
live call at 9:00 a.m. is also available in a listen-only mode by
dialing 212-896-6115. A telephone replay of the call will be
available through August 1, 2002 and can be heard by dialing
800-633-8284 (402-977-9140 for international callers). The
access code for the replay is 207-60-417.
The first national clinical laboratory to fully embrace genomic
testing, Laboratory Corporation of America-Registered
Trademark- Holdings (LabCorp-Registered Trademark-) has been
a pioneer in commercializing new diagnostic technologies. As a
national laboratory with annual revenues of $2.2 billion in 2001
and over 19,000 employees, the Company offers more than 4,000
clinical tests ranging from routine analyses to sophisticated
molecular diagnostics. Serving over 200,000 clients nationwide,
LabCorp combines its expertise in innovative clinical testing
technology with its Centers of Excellence. The Center for
Molecular Biology and Pathology, in Research Triangle Park,
North Carolina, offers state-of-the-art molecular gene-based
testing in infectious disease, oncology and genetics. Its National
Genetics Institute in Los Angeles is an industry leader in
developing novel, highly sensitive polymerase chain reaction
(PCR) methods for testing hepatitis C and other blood borne
infectious agents. LabCorp's Minneapolis-based ViroMed offers
molecular microbial testing using real time PCR platforms, while
its Center for Esoteric Testing in Burlington, North Carolina,
performs the largest volume of specialty testing in the network.
LabCorp's clients include physicians, state and federal
government, managed care organizations, hospitals, clinics,
pharmaceutical and Fortune 1000 companies, and other clinical
laboratories.
Each of the above forward-looking statements is subject to change
based on various important factors, including without limitation,
competitive actions in the marketplace and adverse actions of
governmental and other third-party payors. Further information on
potential factors that could affect LabCorp's financial results is included
in the Company's Form 10-K for the year ended December 31, 2001
and subsequent SEC filings.
4
2
- - more -